DK1419772T3 - Forebyggende middel/behandlende middel mod IBS domineret forstoppelse - Google Patents

Forebyggende middel/behandlende middel mod IBS domineret forstoppelse

Info

Publication number
DK1419772T3
DK1419772T3 DK02705169T DK02705169T DK1419772T3 DK 1419772 T3 DK1419772 T3 DK 1419772T3 DK 02705169 T DK02705169 T DK 02705169T DK 02705169 T DK02705169 T DK 02705169T DK 1419772 T3 DK1419772 T3 DK 1419772T3
Authority
DK
Denmark
Prior art keywords
ibs
constipation
group
dominated
preventive
Prior art date
Application number
DK02705169T
Other languages
English (en)
Inventor
S Yamazaki
Original Assignee
Dynogen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dynogen Pharmaceuticals Inc filed Critical Dynogen Pharmaceuticals Inc
Application granted granted Critical
Publication of DK1419772T3 publication Critical patent/DK1419772T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
DK02705169T 2001-08-24 2002-03-14 Forebyggende middel/behandlende middel mod IBS domineret forstoppelse DK1419772T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001254662 2001-08-24
PCT/JP2002/002402 WO2003018012A1 (fr) 2001-08-24 2002-03-14 Agent pour la prevention/le traitement du syndrome du colon irritable (sci) avec predominance de constipation

Publications (1)

Publication Number Publication Date
DK1419772T3 true DK1419772T3 (da) 2007-11-12

Family

ID=19082790

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02705169T DK1419772T3 (da) 2001-08-24 2002-03-14 Forebyggende middel/behandlende middel mod IBS domineret forstoppelse

Country Status (13)

Country Link
US (2) US20040248927A1 (da)
EP (2) EP1419772B1 (da)
JP (1) JPWO2003018012A1 (da)
KR (1) KR100869759B1 (da)
CN (1) CN1545412A (da)
AT (2) ATE367813T1 (da)
CA (1) CA2457053C (da)
CY (1) CY1106913T1 (da)
DE (2) DE60221402T2 (da)
DK (1) DK1419772T3 (da)
ES (1) ES2289086T3 (da)
PT (1) PT1419772E (da)
WO (1) WO2003018012A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004268641A1 (en) * 2003-08-29 2005-03-10 Dynogen Pharmaceuticals, Inc. Compositions useful for treating gastrointestinal motility disorders
SE0401578D0 (sv) 2004-06-18 2004-06-18 Active Biotech Ab Novel compounds
US20080269276A1 (en) * 2007-02-12 2008-10-30 Dynogen Pharmaceuticals, Inc. Compositions useful for treating irritable bowel syndrome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2699794B2 (ja) * 1992-03-12 1998-01-19 三菱化学株式会社 チエノ〔3,2−b〕ピリジン誘導体
JP3250921B2 (ja) * 1994-11-21 2002-01-28 三菱化学株式会社 腸管運動機能不全性疾患の治療剤
JPH08286450A (ja) 1995-04-19 1996-11-01 Matsushita Electric Ind Co Ltd 画像読取り等複合装置
NZ518579A (en) * 1999-11-23 2003-09-26 Janssen Pharmaceutica Nv Use of 5HT3 agonists for relaxing the fundus-a cause of gastrointestinal disorder
TWI256314B (en) * 2000-02-09 2006-06-11 Mitsubishi Pharma Corp Preventive-therapeutical medicament for gastroesophageal reflux disease

Also Published As

Publication number Publication date
ATE421323T1 (de) 2009-02-15
EP1419772A1 (en) 2004-05-19
DE60221402D1 (de) 2007-09-06
ES2289086T3 (es) 2008-02-01
DE60231017D1 (de) 2009-03-12
EP1419772B1 (en) 2007-07-25
US20070004770A1 (en) 2007-01-04
CN1545412A (zh) 2004-11-10
CA2457053C (en) 2010-10-26
CY1106913T1 (el) 2012-09-26
KR20040047774A (ko) 2004-06-05
EP1829543A1 (en) 2007-09-05
DE60221402T2 (de) 2008-04-03
ATE367813T1 (de) 2007-08-15
EP1419772A4 (en) 2004-11-24
US7897614B2 (en) 2011-03-01
JPWO2003018012A1 (ja) 2004-12-09
CA2457053A1 (en) 2003-03-06
EP1829543B1 (en) 2009-01-21
KR100869759B1 (ko) 2008-11-21
US20040248927A1 (en) 2004-12-09
PT1419772E (pt) 2007-09-05
WO2003018012A1 (fr) 2003-03-06

Similar Documents

Publication Publication Date Title
RU2095062C1 (ru) Блокатор синдрома отмены, являющегося результатом привыкания к чрезмерному потреблению лекарств или веществ, вызывающих привыкание, фармакологическая композиция на его основе и способ облегчения или предотвращения синдрома отмены
MY130755A (en) Colchinol derivatives as vascular damaging agents
ATE370138T1 (de) Neue imidazopyridine und ihre verwendung
MXPA02012034A (es) Derivados de tiofeno utiles como agentes anticancerosos.
IL107426A (en) 3-HALO-8-ARALKOXY (OR ARALKYLAMINO) IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TW200502230A (en) Dual nk1/nk3 derivatives
HUP0102425A2 (hu) Gyomorsav-elválasztást gátló imidazo-piridin-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
TNSN06036A1 (en) Pyridyl derivatives and their use as therapeutic agents
BR0309345A (pt) Composto ou sais farmaceuticamente aceitáveis do mesmo, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, de distúrbios psicóticos ou de distúrbios de dano intelectual, e de jetlag, interrupção do hábito de fumar, dependência de nicotina, ânsias, dor e colite ulcerativa
WO2000002549A2 (en) Composition for and method of treating neurological disorders
MXPA03000252A (es) Derivados de quinolina que tienen actividad de inhibicion de fcev.
TNSN05080A1 (en) NOVEL ANTIMYCOBACTERIAL COMPOUNDS (as filed) AND PYRROLE DERIVATIVES AS ANTIMYCOBACTERIAL COMPOUNDS (as published)
NZ503294A (en) Halogen substituted tetracyclic tetrahydrofuran derivatives and pharmaceutical use
SE9901573D0 (sv) New compounds
WO2000068198A3 (en) Heterosubstituted pyridine derivatives as pde 4 inhibitors
RU2004131680A (ru) Производные бензофурана
EP1228758A4 (en) PROHYLACTIC AND THERAPEUTIC AGENTS FOR INFLAMMABLE COLON DISEASES
NZ518684A (en) Use of a peripheral mu opioid antagonist to treat or prevent ileus
CY1106913T1 (el) Προληπτικος παραγων/θεραπευτικος παραγων δια το συνδρομο της φλογωσεως των εντερων που επικρατει της δυσκοιλιοτητος
ES2284612T3 (es) Agentes preventivos o terapeuticos para regurgitacion gastrica o esofagica.
SE9901572D0 (sv) New compounds
CA2382654A1 (en) Novel a-500359 derivatives
IE63194B1 (en) Antiemesis ergoline derivatives
NZ330832A (en) 5-heterocyclyl-alkyl-3-oxo-N-(heteroaryl or aryl)-pyrido[1,2-a]benzimidazole-4-carboxamide derivatives and medicaments
WO2004050019A3 (en) Method and compositions for treating anxiety